Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer (SUBMIT)
This study has been terminated.
(due to low accrual rate)
Jeroen Bosch Ziekenhuis
First Posted: July 12, 2011
Last Update Posted: February 4, 2014
Borstkanker Onderzoek Groep
Comprehensive Cancer Centre The Netherlands
Information provided by (Responsible Party):
M.F. Ernst, dr, Jeroen Bosch Ziekenhuis
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||January 2014|
|Primary Completion Date:||January 2014 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ruiterkamp J, Voogd AC, Tjan-Heijnen VC, Bosscha K, van der Linden YM, Rutgers EJ, Boven E, van der Sangen MJ, Ernst MF; Dutch Breast Cancer Trialists' Group (BOOG). SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg. 2012 Apr 2;12:5. doi: 10.1186/1471-2482-12-5.